Abstract
Lymphoblastic lymphoma (LBL) is a highly malignant subtype of non-Hodgkin's lymphoma (NHL) and generally carries a T-cell phenotype with mediastinum or central nervous system (CNS) involvement. However, only a small proportion of LBL exhibit a B-cell phenotype (B-LBL), and these frequently present at the head and neck without mediastinum or CNS involvement. Three immunological subgroups may exist. The most predominant CD10-positive pre-B-cell type, corresponding to a precursor B-cell neoplasm, frequently involves the head and neck. The second, CD10-negative or mature B-cell type, defined by the absence of CD10 or presence of surface membrane immunoglobulins combined with expression of CD19 or CD20, often involves the mediastinum. The final group is a CD5-positive B-cell type corresponding to a blastic variant of mantle cell lymphoma (MCL). Its clinical course is less aggressive, patients are often older, and nodal lesions are more frequent than extranodal involvement. Thus, B-LBL is immunologically diverse, but its biological behavior correlates with the immunophenotype.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Borowitz MJ, Croker BP, Metzgar RS (1981) Comparison of histologic and immunologic heterogeneity of non-Hodgkin's lymphomas. Am J Pathol 105:97–106
Borowitz MJ, Croker BP, Metzgar RS (1983) Lymphoblastic lymphoma with the phenotype of common acute lymphoblastic leukemia. Am J Clin Pathol 79:387–391
Cheng A-L, Su I-J, Tien H-F, Wang C-C, Chen Y-C, Wang C-H (1994) Characteristic clinicopathologic features of adult B-cell lymphoblastic lymphoma with special emphasis on differential diagnosis with an atypical form probably of blastic lymphocytic lymphoma of intermediate differentiation origin. Cancer 73:706–710
Cossman J, Chused TM, Fisher RI, Magrath I, Bollum F, Jaffe ES (1983) Diversity of immunological phenotypes of lymphoblastic lymphoma. Cancer Res 43:4486–4490
Freedman AS, Nadler LM (1991) Immunologic markers in non-Hodgkin's lymphoma. Hematol Oncol Clin North Am 5:871–889
Grogan T, Spier C, Wirt DP, Hicks MJ, Paquin M, Hutter J, Miller T, Rangel C, Richter L, Jones S (1986) Immunologic complexity of lymphoblastic lymphoma. Diagn Immunol 4:81–88
Grümayer ER, Ladenstein RL, Stave I, Urban C, Rdaszkiewicz T, Bettelheim P, Gadner H (1988) B-cell differentiation pattern of cutaneous lymphomas in infancy and childhood. Cancer 61:303–308
Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, de Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink H-K, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA (1994) A Revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361–1392
Jacobs JC, Katz RL, Shabb N, El-Naggar A, Ordonez NG, Pugh W (1992) Fine needle aspiration of lymphoblastic lymphoma. A multiparameter diagnostic approach. Acta Cytol 6:887–894
Lardelli P, Bookman MA, Sundeen J, Longo DL, Jaffe ES (1990) Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlations. Am J Surg Pathol 14:752–763
Lavabre-Bertrand T, Janossy G, Ivory K, Peters R, Secker-Walker L, Porwit-MacDonald A (1994) Leukemia-associated changes identified by quantitative flow cytometry. I. CD10 expression. Cytometry 18:209–217
Link MP, Roper M, Dorfman RF, Crist WM, Cooper MD, Levy R (1983) Cutaneous lymphoblastic lymphoma with pre-B markers. Blood 61:838–841
Meyers L, Hakami N (1984) Pre-B cell cutaneous lymphoma in infancy: a unique clinical entity. Med Pediatr Oncol 12:252–254
Picozzi VJ, Coleman CN (1990) Lymphoblastic lymphoma. Semin Oncol 17:96–103
Sander CA, Jaffe ES, Gebhardt FC, Yano T, Medeiros LJ (1992) Mediastinal lymphoblastic lymphoma with an immature B-cell immunophenotype. Am J Surg Pathol 16:300–305
Sander CA, Medeiros LJ, Abruzzo LV, Horak ID, Jaffe ES (1991) Lymphoblastic lymphoma presenting in cutaneous sites. A clinicopathologic analysis of six cases. J Am Acad Dermatol 25:1023–1031
Sheibani K, Nathwani BN, Winberg CD, Burke JS, Swartz WG, Blayney D, van de Velde S, Hill LR, Rappaport H (1987) Antigenically defined subgroups of lymphoblastic lymphoma. Relationship to clinical presentation and biologic behavior. Cancer 60:183–190
Shibata K, Shimamoto Y, Nakano S, Miyahara M, Nakano H, Yamaguchi M (1995) Mantle cell lymphoma with the features of mucosa-associated lymphoid tissue (MALT) lymphoma in an HTLV-I-seropositive patient. Ann Hematol 70:47–51
Shimamoto Y, Suga K, Shibata K, Matsuzaki M, Yano H, Yamaguchi M (1994) Clinical importance of extraordinary integration patterns of human T-cell lymphotrophic virus type I proviral DNA in adult T-cell leukemia/lymphoma. Blood 84:853–858
Tokioka T, Shimamoto Y, Nagumo F, Tadano J, Yamaguchi M (1994) New cell line from hairy-cell leukemia producing interleukin-6 after Epstein-Barr virus immortalization. Acta Haematol 92:8–13
Weiss LM, Bindl JM, Picozzi VJ, Link MP, Warnke RA (1986) Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T-cell acute lymphoblastic leukemia. Blood 67:474–478
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shibata, K., Shimamoto, Y., Yamada, H. et al. Correlation between immunophenotypic diversity and clinical features in B-cell lymphoblastic lymphoma. Ann Hematol 71, 319–323 (1995). https://doi.org/10.1007/BF01697988
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01697988